- Home
- AMBC vs AUTL Comparison
AMBC vs AUTL Comparison
Compare AMBC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- AUTL
- Stock Information
- Founded
- AMBC 1971
- AUTL 2014
- Country
- AMBC United States
- AUTL United Kingdom
- Employees
- AMBC N/A
- AUTL N/A
- Industry
- AMBC Property-Casualty Insurers
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMBC Finance
- AUTL Health Care
- Exchange
- AMBC Nasdaq
- AUTL Nasdaq
- Market Cap
- AMBC 411.3M
- AUTL 431.1M
- IPO Year
- AMBC 1991
- AUTL 2018
- Fundamental
- Price
- AMBC $8.06
- AUTL $1.62
- Analyst Decision
- AMBC Strong Buy
- AUTL Strong Buy
- Analyst Count
- AMBC 1
- AUTL 5
- Target Price
- AMBC $10.00
- AUTL $9.12
- AVG Volume (30 Days)
- AMBC 1.1M
- AUTL 3.9M
- Earning Date
- AMBC 11-11-2025
- AUTL 11-11-2025
- Dividend Yield
- AMBC N/A
- AUTL N/A
- EPS Growth
- AMBC N/A
- AUTL N/A
- EPS
- AMBC N/A
- AUTL N/A
- Revenue
- AMBC $257,879,000.00
- AUTL $29,934,000.00
- Revenue This Year
- AMBC $3.54
- AUTL $641.63
- Revenue Next Year
- AMBC N/A
- AUTL $109.21
- P/E Ratio
- AMBC N/A
- AUTL N/A
- Revenue Growth
- AMBC 148.44
- AUTL 185.17
- 52 Week Low
- AMBC $5.99
- AUTL $1.11
- 52 Week High
- AMBC $13.64
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- AMBC 41.57
- AUTL 50.10
- Support Level
- AMBC $7.91
- AUTL $1.58
- Resistance Level
- AMBC $8.59
- AUTL $1.79
- Average True Range (ATR)
- AMBC 0.53
- AUTL 0.11
- MACD
- AMBC -0.10
- AUTL 0.01
- Stochastic Oscillator
- AMBC 14.57
- AUTL 47.14
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.